Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GNOM vs. FBDIX: which is better?

Bottom line

GNOM vs FBDIX: the short answer

GNOM (Global X Genomics & Biotechnology ETF) and FBDIX (Franklin Biotechnology Discovery Fund) are both etfs.

But FBDIX is far broader, holding 126 positions to 51 for GNOM, so beyond the top names it adds exposure GNOM doesn't have.

GNOM is cheaper at 0.5% vs 1.01% — a difference of $51 a year per $10,000 invested.

Over five years, FBDIX returned +5.0% a year vs −13.3% for GNOM.

FBDIX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

GNOM vs FBDIX side by side

GNOMFBDIX
TypeETFMutual fund
Fund familyGlobal XFranklin Templeton
CategoryTechnology SectorTechnology Sector
Expense ratio0.5%1.01%
Annual cost per $10k$50$101
10-yr cost on $10k (prospectus)$628$1,728
Max front loadNone5.5%
12b-1 fee0%0.25%
1-yr return+19.0%+43.9%
5-yr return (annualized)−13.3%+5.0%
10-yr return (annualized)—+6.4%
Best quarter+38.8%+29.5%
Worst quarter−24.2%−24.5%
Net assets (fund)$55.8M$1.2B
Number of holdings51126
Portfolio turnover34%38%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearGNOMFBDIXDifference
2025+19.0%+52.3%−33.3%
2024−16.2%+4.0%−20.2%
2023−8.6%+18.4%−27.0%
2022−36.1%−12.7%−23.4%
2021−16.0%−17.7%+1.7%
2020+51.6%+29.9%+21.7%

Source: Fund prospectus bar charts

Holdings overlap

6 of GNOM's top 25 holdings also appear in FBDIX's top 25.

Shared top holdings
HoldingGNOMFBDIX
Guardant Health, Inc.5.59%2.76%
Praxis Precision Medicines Inc4.01%1.91%
Vertex Pharmaceuticals Incorporated3.95%3.54%
Eli Lilly And Company2.32%1.31%
Gilead Sciences, Inc.1.95%3.86%
Astrazeneca Plc1.83%1.51%

Source: SEC Form N-PORT

GNOM top 10

  1. Guardant Health, Inc. — 5.59%
  2. Illumina, Inc. — 4.82%
  3. Natera, Inc. — 4.15%
  4. Biomarin Pharmaceutical Inc. — 4.09%
  5. Arrowhead Pharmaceuticals, Inc. — 4.07%
  6. Legend Biotech Corp — 4.05%
  7. Praxis Precision Medicines Inc — 4.01%
  8. Twist Bioscience Corp — 3.97%
  9. Vertex Pharmaceuticals Incorporated — 3.95%
  10. CRISPR Therapeutics AG — 3.85%

FBDIX top 10

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Amgen, Inc. — 4.39%
  3. Gilead Sciences, Inc. — 3.86%
  4. Regeneron Pharmaceuticals, Inc. — 3.77%
  5. Argenx SE — 3.62%
  6. Vertex Pharmaceuticals, Inc. — 3.54%
  7. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  8. Revolution Medicines, Inc. — 3.01%
  9. Guardant Health, Inc. — 2.76%
  10. Ascendis Pharma A/S — 2.56%

FAQ

What is the difference between GNOM and FBDIX?
GNOM (Global X Genomics & Biotechnology ETF) and FBDIX (Franklin Biotechnology Discovery Fund) are both etfs. But FBDIX is far broader, holding 126 positions to 51 for GNOM, so beyond the top names it adds exposure GNOM doesn't have.
Which is cheaper, GNOM or FBDIX?
GNOM has the lower expense ratio (0.5%).
Should I own both GNOM and FBDIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.